Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC. Leung CSK, Van den Eynde BJ. Cancer Cell 2022;40:903-905.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leung CSK, Van den Eynde BJ. Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC. Cancer Cell 2022;40:903-905.
PMID: 36027917